IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q2 2017 Holdings

Filed 2017-08-15 | 5 holdings | $28.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Protagonist Therapeutic, Inc.(PTGX)Common74366E102$11.1K982,27038.5%
Jounce Therapeutics(JNCEEUR)Common481116101$9.3K662,06332.2%
Argos Therapeutics Inc.Common040221103$4.8K13,242,27916.7%
Argos Therapeutics Inc.CallCommon040221103$1.9K5,120,6046.4%
Proteon Therapeutics Inc.Common74371L109$1.8K1,165,3446.2%